Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (PET/MR-P)
This study has been completed.
Washington University School of Medicine
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
Pamela Woodard, MD, Washington University School of Medicine
First received: January 23, 2013
Last updated: May 10, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2015|
|Primary Completion Date:||June 2015 (Final data collection date for primary outcome measure)|